PTFE MEMBRANE SUPPLY BUSINESS PLAN

I. Executive Summary

Company Description

Aegis Membrane Technologies (name chosen to convey protection and material precision) is a U.S.-based manufacturer of high-grade polytetrafluoroethylene (PTFE) membranes located in Newark, Delaware, launching operations in 2026. The company operates in the specialty materials and industrial filtration sector, producing custom-engineered microporous PTFE structures for filtration and waterproofing. Using state-of-the-art extrusion and biaxial stretching equipment, the facility converts granular PTFE into consistent, high-performance sheets and rolls tailored to customer specs. The business opened with a $1,290,000 domestic manufacturing investment to secure supply chain reliability and technical excellence. One-line summary: supplying precision PTFE membranes to U.S. industry with domestic control and engineered performance.

The company sells direct to industrial manufacturers across chemical processing, HVAC, medical device housings, and protective apparel segments, targeting engineering procurement managers and OEM product teams seeking custom material solutions. Competitive edges are tight process control, rapid prototyping, and in-house formulation expertise that shorten lead times and raise yield. Short-term goals are to commence commercial runs in 2026 and achieve $5,405,000 in first-year revenue. Long-term goals are to expand capacity, add two new product grades within three years, and secure multi-year supply contracts with tier-1 OEMs. One-line summary: scale domestic PTFE supply to become the reliable, technical partner for U.S. manufacturers.

Problem

Industrial and technology manufacturers in the U.S. face recurring failures from inadequate component protection and poor process purity—inefficient filtration and insufficient waterproofing allow contaminants into sensitive assemblies, causing equipment failure, product contamination, increased downtime, lower yields, and higher warranty exposure. This directly harms product quality and corporate profitability.

Current market filtration and sealing options often lack the precision required for high-stakes medical and electronic applications, leaving a clear performance gap that delays regulatory approvals and triggers field failures. One line: solving contamination and waterproofing failures protects products and profits.

Launching in Newark, Delaware in 2026 with a $1,290,000 investment in domestic manufacturing and a Year 1 revenue target of $5,405,000, the company addresses this gap by supplying high-grade PTFE membranes engineered for filtration and waterproofing in critical industrial applications.

Solution

We supply US-manufactured PTFE membranes that solve equipment failures and contamination caused by inadequate component protection and inefficient filtration. Our membranes capture submicron particles, provide a waterproof yet vapor-permeable barrier, and replace slow, fragile international supply chains with rapid domestic availability—serving military, aerospace, medical, cleanroom, and OEM applications.

One-liner: high-efficiency, breathable PTFE membranes for critical waterproofing and venting. Key facts: domestic production ensures high-purity batches and rapid delivery to US OEMs; projected EBITDA $2,690,000 in year one; addresses an $18,890,000 market opportunity by 2030.

Mission Statement

We manufacture world-class microporous PTFE materials domestically to enhance industrial performance and product reliability. We deliver custom-engineered PTFE solutions that empower U.S. manufacturers through technical expertise and a lean supply chain, providing superior protection and purity for the most demanding applications. We are committed to creating stakeholder value with a 34.06% Return on Equity.

Key Success Factors

Success is driven by the proprietary JIT production model, a $1,290,000 equipment investment, senior technical staff, fast financial returns, and a strategic U.S. location.

• JIT production model reduces customer lead times and lowers overhead.
• $1,290,000 state-of-the-art equipment ensures superior product performance and consistency.
• Senior Material Scientists and Process Engineers provide essential OEM technical support.
• Rapid financial returns — breakeven in 2 months and 9-month payback.
• Strategic U.S. materials science hub location secures talent and raw-material access.

Financial Summary

The plan forecasts a profitable, high-margin manufacturing business with rapid scale: revenue grows from $5,405,000 in 2026 to $18,890,000 in 2030 and EBITDA from $2,690,000 to $11,326,000.

Financial requirements: capex $1,390,000 (equipment and clean-room build), minimum cash $812,000 (maintained from Feb-26), breakeven in Feb-2026, and payback in 9 months; project IRR is 18.45% and ROE is 34.06%.

Overall outlook: strong cash generation and attractive returns support investor interest.

Funding Requirements

We require USD 2,102,000 in initial funding to complete the Newark facility buildout and hold a minimum cash reserve for launch and early operations.

Financial snapshot: Year 1 revenue USD 5,405,000, Year 5 revenue USD 18,890,000; EBITDA scales from USD 2,690,000 to USD 11,326,000; IRR 18.45%; ROE 34.06%; breakeven Feb-26; payback 9 months; minimum cash balance USD 812,000.